Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Aug;211(8):1333-1334.
doi: 10.1164/rccm.202503-0720ED.

Blurred Boundaries: Rethinking Disease Classifications in Interstitial Lung Disease Using Molecular Signals

Scott M Matson  1 , Philip L Molyneaux  2
Affiliations
Editorial

Blurred Boundaries: Rethinking Disease Classifications in Interstitial Lung Disease Using Molecular Signals

Scott M Matson et al. Am J Respir Crit Care Med. 2025 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ. et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med . 2018;198:e44–e68. - PubMed
    1. Mukherjee M, Lim HF, Thomas S, Miller D, Kjarsgaard M, Tan B. et al. Airway autoimmune responses in severe eosinophilic asthma following low-dose mepolizumab therapy. Allergy Asthma Clin Immunol . 2017;13:2. - PMC - PubMed
    1. McGregor MC, Krings JG, Nair P, Castro M. Role of biologics in asthma. Am J Respir Crit Care Med . 2019;199:433–445. - PMC - PubMed
    1. Michelotti A, de Scordilli M, Bertoli E, De Carlo E, Del Conte A, Bearz A. NSCLC as the paradigm of precision medicine at its finest: the rise of new druggable molecular targets for advanced disease. Int J Mol Sci . 2022;23:6748. - PMC - PubMed
    1. Alqalyoobi S, Smith JA, Maddali MV, Pugashetti JV, Newton CA, Kim JS. et al. Proteomic biomarkers of survival in non–idiopathic pulmonary fibrosis interstitial lung disease. Am J Respir Crit Care Med . 2025;211 - PMC - PubMed

LinkOut - more resources